Changes in Licensing and Regulations Related to Healthcare and Pharmaceuticals
First written in FY2020. 2 of 3 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2018: 20 of 65 companies on the "Worse" side.
47 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「Our group is subject to the medical insurance system and regulations under the Pharmaceuticals and Medical Devices Act (the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices).」
Reiterates the potential impact of changes to the medical insurance system, the Pharmaceuticals and Medical Devices Act, licensing requirements for the sale of pharmaceuticals and medical devices, and overseas regulations. - FY2022RestatedAnnual report
「Our group is subject to the medical insurance system and regulations under the Pharmaceuticals and Medical Devices Act (the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices).」
Reiterates the potential impact of changes to the medical insurance system, the Pharmaceuticals and Medical Devices Act, licensing requirements for the sale of pharmaceuticals and medical devices, and overseas regulations. - FY2020First statedAnnual report
「Our group is subject to the medical insurance system and regulations under the Pharmaceuticals and Medical Devices Act. If major institutional changes are made to the laws and regulations described above and the software we provide must be modified, the resulting increase in workload could affect our group’s operating results.」
Describes the impact of changes to the medical insurance system, the Pharmaceuticals and Medical Devices Act, and licensing requirements on the business plan and the burden of modifying the software.